New Delhi, Dec. 10 -- India plans to get its drug regulatory system audited and rated by the World Health Organization (WHO) to detect specific strengths and weaknesses that will help to make it fool proof, according to four officials and a document reviewed by Mint.

The move comes after multiple instances of drug safety related incidents in the country as well as export markets raised serious questions on the quality of medicines made in India, often referred to as 'pharmacy of the world'. India faces multiple challenges in drug quality given the sheer scale of the industry, comprising thousands of manufacturers regulated by varying state-level standards.

Under the proposed assessment, WHO will evaluate India's regulatory system to ass...